At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Alternative Provision of Medication Abortion Via Pharmacy Dispensing
In Brief
A Phase 4 clinical trial evaluating Mifepristone and Training on mifepristone dispensing for Pregnancy Related and Abortion Early. Completed, enrolled 326 participants across 6 sites.
Detailed Summary
This mixed-methods study follows a prospective cohort of patients receiving Mifeprex ® (mifepristone) for medication abortion dispensed by pharmacists after undergoing standard clinical evaluation. Women participating in this study will obtain mifepristone and misoprostol from the pharmacy instead of in the clinic. To assess feasibility, acceptability, and effectiveness of pharmacy dispensing of mifepristone, the study will survey patients, evaluate their clinical outcomes from electronic health records, and survey and interview pharmacists at study sites.
Study Details
Timeline
Interventions
Patients will receive Mifeprex® (mifepristone) by pharmacy rather than standard care at clinic visit
Pharmacists were offered a training on medication abortion and mifepristone dispensing